(Q28145730)

English

Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study

scientific article (publication date: March 2000)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study (English)

0 references

1 reference

P O Hedlund

1

0 references

P Henriksson

series ordinal

2

0 references

language of work or name

English

0 references

publication date

March 2000

0 references

published in

Urology

0 references

volume

55

0 references

issue

3

0 references

page(s)

328-33

0 references

Identifiers

DOI

10.1016/S0090-4295(99)00580-4

0 references

PubMed ID

10699602

0 references

(Q28145730)

Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. The Scandinavian Prostatic Cancer Group (SPCG)-5 Trial Study

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)